Neurological soft signs in psychometrically identified schizotypy by Kaczorowski, Jessica & NC DOCKS at The University of North Carolina at Greensboro
KACZOROWSKI, JESSICA, M.A. Neurological Soft Signs in Psychometrically 
Identified Schizotypy. (2008) 
Directed by Dr. Thomas R. Kwapil. 79 pp. 
 
 
Patients with schizophrenia often exhibit structural b in abnormalities, as well as 
neurological soft signs, consistent with its conceptualization as a neurodevelopmental 
disorder. Neurological soft signs are mild, presumably nonlocalizing, neurological 
impairments that are inferred from performance deficits in domains such as sensory 
integration, motor coordination, and motor sequencing. The vulnerability for 
schizophrenia is presumed to be expressed across a broad continuum of impairment 
referred to as schizotypy. It is hypothesized that nondisordered people along the 
schizotypy continuum should exhibit elevated rates of neurological soft signs. The 
present study examined the relation of psychometrically identified positive and negative 
schizotypy with neurological soft signs using the Nurological Evaluation Scale (NES) in 
a nonclinically ascertained sample of young adults (n = 177). As hypothesized, negative, 
but not positive, schizotypy was related to increased neurological soft signs in tasks that 
assessed fine and gross motor coordination, motor sequencing, eye movement 
abnormalities, and memory recall. However, positive schizotypy was associated with 
increased neurological soft signs in tasks related to sensory integration dysfunction. In 
general, the positive x negative schizotypy interaction term was unrelated to individual 
neurological soft sign tasks. The findings support: a) the theory that the vulnerability for 
schizophrenia is expressed across a broad continuum of subclinical and clinical 
impairment referred to as schizotypy; b) the multidimensional structure of schizotypy; 
 
 
and c) the notion that schizotypy is an appropriate construct for understanding the 
etiology and development of schizophrenia-spectrum disorders. 
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CHAPTER I 
INTRODUCTION 
Patients with schizophrenia exhibit structural brain bnormalities, as well as 
neurological soft signs, consistent with the conceptualization of schizophrenia as a 
neurodevelopmental disorder. Current neurodevelopmental models posit that the 
vulnerability for schizophrenia is expressed across a dynamic continuum of clinical and 
subclinical impairment referred to as schizotypy. The present study examined the 
expression of neurological soft signs in psychometrically identified positive and negative 
schizotypy.  
Schizophrenia 
Schizophrenia involves a family of severe mental disorders that, in their extreme, 
are characterized by the presence of psychotic and resi ual symptoms, as well as a 
marked decline in functioning (American Psychiatric Association, 2000). These 
symptoms are often classified as positive, negative, and disorganized. Positive (or florid) 
symptoms reflect an excess or distortion of normal functions such as delusions and 
hallucinations. Negative (or deficit) symptoms reflect a diminution or loss of normal 
functions such as social anhedonia, affective flattening, alogia, and avolition. Cognitive 
and behavioral disorganization includes formal thought disorder, inappropriate affect, and 
gross disruptions in behavior. Attenuated and transient forms of positive and negative 
symptoms are often exhibited by nondisordered people who are presumed to be 
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vulnerable for schizophrenia, whereas disorganized symptoms appear to be more of a 
disease marker for full-blown schizophrenia (i.e., disorganized symptoms predominately 
occur in prodromal and spectrum disorder patients, not in nondisordered schizotypes). 
Current etiological models conceptualize schizophrenia as a neurodevelopmental, 
rather than a neurodegenerative, disorder1 (e.g., Weinberger, 1987; Meehl, 1990; 
Andreasen, 1999; Keshavan, Kennedy, & Murray, 2004). The neurodevelopmental 
hypothesis posits that the liability for schizophrenia arises from neural dysmaturation – a 
subtle disruption in brain development that begins in the prenatal period and culminates 
in late adolescence or early adulthood (Andreasen, 1999). Neural dysmaturation does not 
necessarily lead to schizophrenia, but rather is expressed across a continuum of 
impairment referred to as schizotypy (Meehl, 1990). This formulation suggests that 
schizophrenia and schizophrenia-spectrum disorders can be best conceptualized as the 
most severe manifestations of schizotypy. Thus, neural dysmaturation appears to be 
necessary, but not sufficient for the development of full-blown schizophrenia, and is 
expressed across the schizotypy continuum. 
The process of neural dysmaturation is presumed to result from the interaction of 
multiple risk factors including genetic inheritance, g ne expression, pre- and perinatal 
insults, and other biopsychosocial stressors. Althoug  neural dysmaturation occurs across 
development, there are several critical periods in which disruptions in neural 
development markedly heighten the risk for schizotypy, and thus schizophrenia (e.g., 
                                                
1 The etiology of schizotypy and spectrum disorders involves a process of disrupted neural development. 
However, it has been suggested that negative symptom schizophrenia, as well as the consequences of the 
disorder, may result in neurodegeneration in patients with an unremitting course of illness (Jarskog, 
Gilmore, & Lieberman, 2004).  
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Cannon et al., 2003). These include disruptions in crest cell migration during the second 
trimester in utero, perinatal complications (often involving periods of hypoxia), and 
disruptions in the timing and nature of synaptic pruning (apoptosis). Synaptic pruning is a 
normal molecular process that typically occurs in adolescence and results in massive 
planned cell death and neural reorganization (Andersen, 2003). It ideally results in 
increased synaptic (and by extension, cognitive) effici ncy. Disruptions in the timing and 
nature of synaptic pruning can result in brain organiz tion that leaves an individual 
vulnerable for schizophrenia (Keshavan, Anderson, & Pettegrew, 1994).  
The neurodevelopmental hypothesis has been supported by the presence of 
neurological abnormalities in patients with schizophrenia. For example, first-episode 
patients often have increased ventricular and decreased hippocampal, cerebellar, and 
whole brain volume (e.g., Steen, Mull, McClure, Hamer, & Lieberman, 2006; Bottmer et 
al., 2005). These findings are consistent with functio al deficits reported both in fMRI 
(e.g., Keedy, Ebens, Keshavan, & Sweeney, 2006) and neuropsychological studies (e.g., 
Antonova, Sharma, Morris, & Kumari, 2004). In addition, patients with schizophrenia 
have elevated rates of atypical handedness including left-, mixed-, and ambiguous-
handedness (Satz & Green, 1999). Green, Satz, Smith, & Nelson (1989) suggest that 
disruptions in neural development could partially erode the substrate for manual 
dominance, resulting in less complete dominance and mixed-handedness. Crow (e.g., 
Crow et al., 1989) maintains that schizophrenia results, in large part, from disruptions in 
cerebral lateralization, not only in motor functioning, but in cognitive and affective 
processing as well. Taken together, the presence of a wide array of neurological 
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abnormalities in the premorbid, acute, and residual ph ses of schizophrenia supports a 
neurodevelopmental process that predates the clinical manifestation of schizophrenia and 
remains relatively stable over time.  
Schizotypy 
Schizotypy represents the personality expression of the neurodevelopmental 
vulnerability for schizophrenia (Meehl, 1990). Although the majority of people with this 
vulnerability will never decompensate into clinical schizophrenia2, they often exhibit 
mild or transient features of the disorder including cognitive, emotional, and 
biobehavioral symptoms. This suggests that schizotypy is expressed along a dynamic 
continuum ranging from relative psychological health to subclinical deviance to 
schizophrenia-spectrum personality disorders to full-blown schizophrenia. In other 
words, schizophrenia and schizophrenia-spectrum personality disorders represent the 
most deviant clinical expressions along this continuum. In addition, schizotypy is 
multidimensional in nature, with positive and negative schizotypy being the most 
consistently replicated factors (e.g., Claridge et al., 1996; Kwapil, Barrantes-Vidal, & 
Silvia, 2008; Vollema & van den Bosch, 1995). Taken together, schizotypy appears to be 
expressed along a dynamic continuum with features paralleling those associated with 
full-blown schizophrenia.  
There is considerable evidence that supports the scizotypy continuum as an 
expression of neurodevelopmental vulnerability for schizophrenia. First of all, patients 
                                                
2 Meehl (1990) suggested that about 10% of the population is schizotypic and that about 10% of 
schizotypes will decompensate into schizophrenia (ne tly arriving at the 1% lifetime prevalence rate for 
schizophrenia). Meehl’s conjectures were not empirically derived or tested; however, subsequent 
taxometric analyses have supported his estimates (e.g., L nzenweger & Korfine, 1992; Horan, Blanchard, 
Gangestad, & Kwapil, 2004). 
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with schizophrenia are known to exhibit mild and transient signs of the disorder long 
before they decompensate (e.g., Walker, Savoie, & Davis, 1994; Chapman, Chapman, 
Kwapil, Eckblad, & Zinser, 1994). Second, compensated relatives of patients with 
schizophrenia (who are presumed to share genetic liability) often exhibit signs of 
schizotypy, including cognitive, affective, and bioehavioral symptoms (e.g., 
Erlenmeyer-Kimling et al., 1993; Cannon et al., 1994). Third, putative schizotypes 
identified by clinical status or psychometric inventories exhibit similar patterns of 
cognitive and biobehavioral deficits (e.g., impairment in sustained attention, 
dermatoglyphic anomalies, and some evidence of atypical handedness) as patients with 
schizophrenia (e.g., Bergida & Lenzenweger, 2006; Chok, Kwapil, & Scheuermann, 
2005; Chapman & Chapman, 1987), albeit to a lesser deg ee.  
Taken together, this evidence suggests that the schizotypy continuum is a 
promising construct from which to study the neurodevelopment of schizophrenia. In 
addition, the identification and study of nondisordered schizotypes: 1) avoids confounds 
associated with the catastrophic sequelae of schizop renia itself (such as hospitalization, 
medication, and social stigma); 2) should enhance our understanding of the etiology and 
development of schizophrenia spectrum disorders, including the identification of risk and 
protective factors; and 3) is essential for the development and implementation of 
prophylactic treatment interventions.   
Lenzenweger (1998) reviewed the relative strengths and weaknesses of three 
broad (and by no means mutually exclusive) methods f r identifying schizotypy: familial, 
clinical, and psychometric-laboratory index approaches. The familial method is the best-
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known, due in large part to landmark studies of the offspring of schizophrenic patients 
including the work by Fish (e.g., 1987), the Copenhagen High-Risk Project (e.g., Cannon 
& Mednick, 1993), and the New York High-Risk Project (e.g., Erlenmeyer-Kimling et 
al., 1998). The clinical method identifies high-risk ndividuals based upon schizophrenia-
spectrum diagnoses, such as schizotypal personality disorder, or prodromal status. This 
method has been employed by Cornblatt and colleagues’ Research and Prevention Clinic 
at Hillside Hospital (e.g., Cornblatt, 2001). The final method involves the use of 
psychometrically sound research instruments designed to identify symptom, trait, 
neurocognitive, and biobehavioral markers of vulnerability. Although all three methods 
have their strengths and limitations, the psychometric high-risk method provides several 
notable advantages. First, these measures can be used to creen a large number of 
individuals from the general population, rather than selecting participants based upon 
clinical status or consanguinity. Given that only about 15% of patients with schizophrenia 
have a known 1st degree relative with the disorder, family studies provide a stratified 
group of at-risk participants that is not wholly rep sentative of future sufferers. 
Psychometric screening inventories also tend to be relatively noninvasive and 
inexpensive to administer and score. Finally, they can be used in conjunction with other 
measures of risk including family studies – as has been demonstrated by research such as 
the New York High Risk Project (e.g., Erlenmeyer-Kimling et al., 1993). 
Importantly, identifying people along the schizotypy continuum with 
psychometric risk inventories has reliably predicted schizophrenia symptoms or spectrum 
disorders at follow-up assessments. For example, Chapman et al. (1994) re-interviewed 
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95% of 534 putatively schizotypic and control participants at a ten-year follow-up 
assessment. They found that participants initially dentified by the Magical Ideation 
(Eckblad & Chapman, 1983) and Perceptual Aberration (Chapman, Chapman, & Raulin, 
1978) Scales had higher rates of psychosis compared to control participants at the follow-
up assessment. Moreover, participants who were identified by the scales at the initial 
assessment, but did not develop psychosis, still displayed more schizotypal, paranoid, and 
psychotic-like symptoms compared to the control group at the follow-up assessment. 
Finally, Chapman et al. found that 40% of participants who initially scored high on the 
Magical Ideation scale and above the mean on the Revised Social Anhedonia Scale 
(Eckblad, Chapman, Chapman, & Mishlove, 1982) exhibited psychosis at the follow-up 
assessment. In addition, Kwapil (1998) found that 24% of participants identified by the 
Revised Social Anhedonia Scale compared to 1% of the controls exhibited schizophrenia-
spectrum illnesses at the ten-year follow up assessm nt. 
In summary, the neurodevelopmental vulnerability for schizophrenia is expressed 
across a dynamic continuum referred to as schizotypy. Although the majority of 
schizotypes will never decompensate into full-blown schizophrenia, it is hypothesized 
that they will exhibit subtle signs of the disorder that are suggestive of neurological 
abnormalities or neural dysmaturation.  
Neurological Soft Signs 
Neurological abnormalities are traditionally divided into “hard” and “soft” signs. 
Hard signs are clear neurological insults that are localizable to specific brain pathology 
resulting from illness, injury, or toxins. In contrast, soft signs are presently considered 
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mild, nonlocalizable, neurological abnormalities that are inferred from performance 
deficits in domains such as sensory integration, motor coordination, and motor 
sequencing (Buchanan & Heinrichs, 1989). Rather than di gnosing specific brain 
pathology, the current view holds that elevated levels of neurological soft signs indicate a 
generalized disruption in neural circuitry between cortical and subcortical areas (e.g., 
Heinrichs & Buchanan, 1988). In this way, neurological soft signs may reflect a 
phenotypic expression of neural dysmaturation. In fact, Chan and Gottesman (2008) 
recently suggested that neurological soft signs mayrepresent an endophenotype for 
schizophrenia (i.e., a phenotypic expression that is more proximal than the disorder to the 
genetic diathesis). However, the distinction between hard and soft signs tends to be 
artificial, as neurological soft signs are often grouped to reflect their likely 
neuroanatomical and neurofunctional involvement (Bombin, Arango, & Buchanan, 
2005). In fact, the advent of sophisticated structural and functional imaging capabilities 
has increasingly linked neurological soft signs to identifiable, albeit subtle, neurological 
abnormalities. Some researchers suggest discarding the term “neurological soft signs” for 
a more general term such as “neurological exam abnormalities” (Sanders & Keshavan, 
1998). However, the term “neurological soft signs” will be used throughout this paper to 
be consistent with the schizophrenia literature.  
A paucity of studies have examined the neuroanatomical correlates of 
neurological soft signs. However, these studies support the notion that neurological soft 
signs tap an underlying deficit in neural circuitry. For example, Dazzan et al. (2004) 
found both motor and sensory neurological soft signs were related to a decrease in gray 
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matter volume in subcortical structures for patients with first-episode psychosis. Sensory 
integration deficits were also related to a reduction in cerebral cortex volume. 
Furthermore, Dazzan et al. (2006) reported that heal hy individuals with increased rates 
of neurological soft signs displayed an associated reduction of cortical areas similar to 
those seen in the above study with patients with psychosis. In addition, Keshavan et al. 
(2003) found that in first-episode patients with psychosis, greater impairment on a 
cognitive/perceptual neurological soft sign factor was associated with smaller volumes in 
the left heteromodal association cortex and the cerbellum; however, motor abnormalities 
were related to reduced right and left caudate and cerebellar volumes, but not the 
heteromodal cortex. These findings support the current view that neurological soft signs 
suggest a general impairment in subcortical and cortical regions and functional systems. 
Future research employing more precise technology may help link neurological soft signs 
to specific brain pathology.  
Assessment of neurological soft signs in schizophrenia. The reliable assessment of 
neurological soft signs provides a useful index of neurodevelopmental disruption. A 
number of batteries are used to assess neurological imp irment in schizophrenia 
including the Neurological Evaluation Scale (NES; Buchanan & Heinrichs, 1989), the 
Cambridge Neurological Inventory (Chen et al., 1995), the Woods Scale (Woods, 
Kinney, & Yurgelun-Todd, 1986), the Heidelberger Scale (Schroder et al., 1991), the 
Condensed Neurological Examination (Rossi et al., 1990), and the Modified Quantified 
Neurological Scale (Convit, Jaegar, Lin, Meisner, & Volvaka, 1988). The NES is the 
most widely used structured examination to assess nurological impairment in 
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schizophrenia. Therefore, the proposed study and literature review will focus on this 
measure. However, this is not meant to imply that te other measures are not useful tools 
to assess neurological impairment in schizophrenia.  
Neurological Evaluation Scale. The NES was developed based on a literature 
review of neurological status of patients with schizophrenia (Heinrichs & Buchanan, 
1988). Three broad categories of neurological soft signs emerged. These categories, 
based on conceptual considerations of neuroanatomy and function, comprise the NES 
subscales of sensory integration, motor coordinatio, and motor sequencing (Buchanan & 
Heinrichs, 1989). Sensory integration dysfunction indicates a deficit in combining 
information from different sensory inputs, such as failing to match a pattern of auditory 
stimuli with a corresponding pattern of visual stimuli. Motor coordination dysfunction 
suggests a deficit in general motor coordination, such as having difficulty walking in a 
straight line, heel to toe. Motor sequencing dysfunction indicates a deficit in coordinating 
and sequencing repetitive motor actions, such as failing or hesitating to change hand 
positions between a fist and a ring. In addition, the NES includes an “other” composite 
which includes tasks that assess fine motor movement, memory recall, and eye movement 
abnormalities. Finally, the battery assesses cerebral dominance in terms of hand, foot, and 
eye use.  
The NES consists of 26 tasks, with 14 of these assessed and scored bilaterally. 
Most subtests are scored ordinally; however, recent studies suggest that a continuous 
scoring method that includes error count and latency may be superior to the original 
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system (Sanders et al., 1998; Sanders et al., 2006). See Table 1 for a summary of the 
subtests that comprise each subscale. 
The NES literature is inconsistent regarding the scoring of the 14 bilateral tasks 
with studies using summed scores (e.g., Bollini et al., 2007), mean scores (e.g. Malla et 
al., 1997), the higher of the two scores (e.g. Scheffer, 2004; Keshavan et al., 2003), or 
failing to report the analytic strategy at all. Note that psychometric limitations of these 
approaches are discussed later. The lack of discussion urrounding this issue is surprising 
given the potential utility of understanding the relation between neurological soft signs 
and cerebral lateralization in the neurodevelopment of schizophrenia. 
Neurological Soft Signs and Schizophrenia  
Numerous studies indicated that neurological impairment is greater in patients 
with schizophrenia than among nonpsychiatric controls (e.g., Heinrichs & Buchanan, 
1988; Bombin et al., 2005). Approximately 50-65% of patients relative to 5% of 
nondisordered comparison participants exhibit neurological soft signs. Furthermore, 
multiple studies have reported increased neurological soft signs in first-episode patients 
with schizophrenia compared to control groups (Bombin et al., 2005), suggesting that 
neurological soft signs do not simply reflect consequences of chronic illness. Sanders, 
Keshavan, and Schooler (1994) and Scheffer (2004) found that neuroleptic naïve patients 
with first-episode schizophrenia were more impaired on the NES total and subscale 
scores than healthy comparison participants. Venkatasubramanian et al. (2003) found 
similar results, as never treated, drug naïve patients with schizophrenia scored 
significantly worse than healthy control participants on the NES subscales. Keshavan et 
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al. (2003) reported that patients with first-episode schizophrenia were especially impaired 
on sensory and cognitively related NES tasks compared to patients with 
nonschizophrenic psychosis and healthy comparison participants. On motor tasks, 
however, both the schizophrenia and nonschizophrenia psychosis groups had higher 
ratings than the control group.  
Gross neurological impairment is more prevalent in males compared to females 
with schizophrenia. However, a majority of studies suggest that the presence and severity 
of neurological soft signs does not differ by sex (Bombin et al., 2005). In addition, 
although some researchers found that medication use influ nces performance on 
neurological examinations (e.g., Merriam, Kay, Opler, Kushner, & van Praag, 1990; 
Goldstein et al., 2005), Bombin et al. reported that most studies did not find a relation 
between neurological soft signs and antipsychotic medication use.  
Neurological soft signs and course of schizophrenia. Neurological soft signs 
appear to be present prior to the onset of schizophrenia. For example, increased motor 
abnormalities have been found in preschizophrenic children (e.g., Walker & Lewine, 
1990; Walker, Savoie, & Davis, 1994; Rosso et al., 2000) and may reflect neural 
dysmaturation that begins in prenatal development (Walker et al., 1994). Moreover, 
neurological soft signs appear to remain relatively stable over time. A number of cross-
sectional studies did not find an association betwen neurological soft signs and illness 
length (e.g., Gupta et al., 1995; Ismail, Cantor-Graae, Cardenal, & McKeil, 1998; 
Venkatasubramanian et al., 2003; Chen, Lam, Chen, & Nguyen, 1996). However, Yazici, 
Demir, Yazici, and Gogus (2002) found schizophrenia illness duration positively 
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correlated with the NES motor sequencing subscale score and suggested that this 
neurological soft sign domain may progressively deteriorate with age. Several 
longitudinal studies examined the progression of neurological impairment over the course 
of the schizophrenia. Neither Smith, Hussain, Chowdhury, and Sterns (1999), nor 
Emsley, Turner, Oosthuizen, and Carr (2005) found significant changes in overall 
neurological soft sign impairment over five-year and one-year periods, respectively. 
However, Emsley et al. reported performance on motor sequencing tasks in patients with 
first-episode schizophrenia significantly improved at three months, but did not change at 
six or twelve months. Conversely, Madsen, Vorstrup, Rubin, and Larsen (1999) found a 
higher incidence of neurological abnormalities over a five-year period. Given that 
patients with unremitting symptoms also received higher or more continuous doses of 
medication, it is difficult to disentangle the effects of symptom course and severity from 
the consequences of medication (Bombin et al., 2005). Chen, Kwok, Au, Chen, and Lau 
(2000) reported higher rates of neurological soft sign  in chronic patients over a three-
year period, but suggested that the findings may be due to the potential deterioration 
process that occurs late in illness. Taken together, neurological soft signs seem to predate 
the appearance of schizophrenia, be present at illness onset, and remain relatively stable 
over time. 
Neurological soft signs and symptom dimension. Multiple studies have assessed 
the relation between the positive and negative (deficit) symptom dimensions of 
schizophrenia and neurological soft signs. Evidence suggests an association between 
negative symptoms and neurological soft signs (e.g., Merriam et al., 1990; Smith, 
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Kadewari, & Rosenberger, 1999; Scheffer, 2004). Specifically, negative symptoms are 
consistently associated with neurological impairment r lated to sensory integration and 
motor sequencing (Bombin et al., 2005). Buchanan, Kirkpatrick, Heinrichs, and 
Carpenter (1990) found that deficit patients exhibited significantly more neurological soft 
signs than nondeficit patients, and this difference was even larger on the NES sensory 
integration subscale. Moreover, several studies found that overall neurological 
impairment was related to severity of negative sympto s (e.g., Yazici et al., 2002; 
Scheffer, 2004). However, a few studies (e.g., Bartko, Zador, Horvath, & Herezeg, 1988; 
Rubin et al., 1994; Chen, Lam, Chen, & Nguyen, 1996) failed to find a significant 
relation between negative symptoms and neurological impairment. Bombin et al. 
suggested that these studies did not include tasks hat assessed neurological soft signs in 
the domains of motor sequencing and sensory integration.  
In contrast to the negative symptom dimension of schizophrenia, there is little 
evidence to suggest a relation between neurological soft signs and positive symptoms 
(Bombin et al., 2005). Multiple studies failed to find an association between neurological 
soft signs and the positive dimension (e.g., Braun et al., 1995; Buchanan, Koeppl, & 
Breier, 1994; Yazici et al., 2002). Although some studies (e.g., Compton et al., 2007; 
King, Wilson, Cooper, & Waddington, 1991; Mohr et al., 1996; Scheffer, 2004) did find 
a significant relation between neurological soft sign  and positive symptoms, these 
studies also reported a relation between neurological soft signs and negative symptoms. 
This may reflect the co-occurrence of positive and negative symptoms in these groups 
(Bombin et al, 2005). Moreover, Scheffer reported an association between positive and 
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negative symptoms and neurological soft signs at baseline, but only negative symptoms 
remained related to neurological soft signs at a 6-week follow-up. In addition, Schroder 
et al. (1991) and Whitty et al. (2003) found a reduction in neurological soft signs upon 
acute psychotic state remission. This suggests the prevalence of neurological soft signs 
oscillates with positive symptoms and remains constant with negative symptoms, 
consistent with the episodic nature of positive symptoms as opposed to the trait-like 
expression of negative symptoms. Moreover, acute positive symptoms may interfere with 
accurate neurological assessment because hallucinations nd delusions may interfere with 
patients’ ability to understand and comply with task directions (Bombin et al., 2005). 
Thus, there is considerable evidence suggesting an association between neurological soft 
signs and the negative symptom dimension of schizoprenia, but the relationship with the 
positive symptom dimension appears weak at best. 
Neurological soft signs and other forms of psychopathology. Neurological soft 
signs have been observed in patients with disorders other than schizophrenia (Bombin et 
al., 2005). However, individuals with schizophrenia exhibit more neurological soft signs 
than patients with substance abuse (Kinney, Yurgelun-Todd, & Woods, 1999; Mohr et 
al., 1996), bipolar disorder (Kinney et al., 1999), obsessive compulsive disorder (Bolton 
et al., 1998), nonschizophrenic psychosis (Keshavan et l., 2003), and mood disorders 
(Krebs, Gut-Fayand, Bourdel, & Olie, 2000; Boks, Liddle, Burgerhof, Knegtering, & van 
den Bosch 2004). Although neurological soft signs are not unique to schizophrenia, 
examining these characteristics across the schizotypy continuum may further enhance our 
ability to identify individuals at risk for schizophrenia and related disorders.  
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Neurological Soft Signs and Schizotypy 
The continuum model of schizotypy posits that nondisordered individuals along 
the schizotypy continuum should experience mild and transient forms of the symptoms 
and impairment experienced by patients with schizophrenia, including the expression of 
neurological soft signs. A few studies suggest that t e rates and severity of neurological 
soft signs in putative schizotypes is between that of patients with schizophrenia and 
healthy controls (e.g., Cantor-Graae et al., 1994; Chen et al, 2000; Lawrie et al., 2001). 
Yazici et al. (2002) reported that nonpsychotic siblings of patients with schizophrenia 
scored between patients and healthy controls on all NES subscales. Ismail, Cantor-Graae, 
and McNeil (1998) found both patients with schizophrenia and their nonpsychotic 
siblings scored significantly higher than normal comparisons on neurological 
abnormalities, including hard signs, soft signs, and primitive reflexes. Moreover, levels of 
neurological soft signs were positively correlated within patient-sibling pairs. Hans et al. 
(1999) reported that adolescent offspring of patients with schizophrenia showed poorer 
neurobehavioral functioning relative to offspring of healthy controls. In contrast, other 
studies (e.g., Appels et al., 2002; Egan et al., 2001) failed to find significant differences 
in neurological impairment between normal controls and nonpsychotic relatives of 
patients with schizophrenia. Taken together, the dose-wise relation of neurological soft 
signs with schizophrenia and schizotypy suggests that soft signs are a promising marker 
of schizotypy and vulnerability for developing spectrum disorders.  
At the time of this review, four published studies examined the relation between 
neurological soft signs and psychometrically identified schizotypy in nonclinically 
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ascertained samples. Barrantes-Vidal et al. (2002) found that negative and combined 
positive-negative schizotypy clusters reported more neurological soft signs than the 
control or positive schizotypy clusters. In contrast, Obiols, Serrano, Caparros, Subira, and 
Barrantes-Vidal (1999) failed to find a relationship between neurological soft signs and 
positive or negative schizotypy. Barkus, Stirling, Hopkins, and Lewis (2006) reported 
that high scorers on the Unusual Experiences subscale from the Oxford Liverpool 
Inventory of Feelings and Experiences (Mason, Claridge, & Jackson, 1995) and the 
Launay-Slade Hallucination Scale (Launay & Slade, 1981) (two scales that tap positive 
schizotypy) scored significantly higher than control participants on the NES  “total” and 
“others” subscales. However, they did not examine the presence of negative schizotypy in 
their sample. Bollini et al. (2007) found that intervi wer-assessed, but not self-reported, 
schizotypy was related to increased neurological soft signs. In general, however, a 
paucity of studies have examined neurological soft igns in psychometrically identified 
schizotypy.  
Limitations of Previous Research  
  Although the presence and relation between neurological soft signs and 
schizophrenia is well-documented, limitations in the manner in which the NES is used 
and the results are reported weaken conclusions that can be drawn from the literature. For 
example, the internal consistency of each NES subdomain is rarely reported. Although a 
few studies have reported adequate internal consiste cy values, the heterogeneity of 
schizophrenia, raters, and research questions prevents the assumption of adequate internal 
consistency across studies. In addition, information about the distributions of scores on 
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individual NES tasks and subdomains is rarely described in the literature. This is 
problematic for a number of reasons: 1) it is difficult to evaluate whether the analytic 
strategy was appropriate to use with the nature of data (e.g., parametric analyses are unfit 
for highly skewed data); and 2) it prevents researchers from determining whether NES 
tasks are useful to detect less severe manifestations of neurological impairment. In 
addition, a large proportion of studies do not repot interrater reliability values from the 
actual study, but rather agreement values from rater training (i.e., subjects who were not 
included in the study, but used to familiarize the raters with the NES battery). Given the 
complexity of the NES battery and the attention to detail needed to accurately measure 
each task, interrater reliability is needed to ensure measurement reliability. Moreover, 
bilateral task scores are often collapsed by taking the average or the higher of the two 
ratings, without considering whether this is conceptually or empirically justified. For 
example, studies typically do not report whether performance on the two hands are 
correlated before combining them. Studies that do not collapse bilateral task scores 
typically only differentiate between right and left hand performance across subjects, 
rather than dominant and nondominant hand performance. Finally, the majority of studies 
either do not examine the effects of symptom dimensions or use zero-order correlations 
to assess the relation between neurological soft signs and positive and negative 
symptoms. This analytic strategy does not remove the variance associated with one 
symptom dimension from the other and fails to provide information about the unique 
contribution of each dimension to the prediction of neurological soft signs.  
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Goals and Hypotheses of the Present Study  
The present study examined the relations of psychometrically identified positive 
and negative schizotypy, and their interaction, with neurological soft signs in a 
nonclinically ascertained sample of young adults. Unlike many psychometric schizotypy 
studies that arbitrarily select high and low scorers, this study examined the relationship of 
positive and negative schizotypy with neurological soft signs across a broad range of the 
continua. Consistent with the schizophrenia literature, it was hypothesized that negative, 
but not positive, schizotypy would be associated with elevated NES scores. Furthermore, 
it was predicted that the interaction of positive-negative schizotypy would account for 
significant increments in variance over and above the schizotypy main effects, given the 
findings of Barrantes-Vidal et al. (2002) and Barkus et al. (2006).  
The extent to which neurological soft signs were repo ted in a nonclinically 
ascertained sample was examined. One goal was to determine whether measures like the 
NES, which were developed for use with schizophrenia patients, would be useful for 
detecting mild neurological soft signs across the schizotypy continuum. This was of 
particular interest given the lack of information in the literature regarding the distribution 
of neurological soft signs. In addition, the traditional ordinal scoring system (Buchanan & 
Heinrichs, 1989) was compared to a continuous scoring method that included error count 
and latency (Sanders et al., 1998; Sanders et al., 2006) to determine whether measuring 
neurological soft signs continuously would capture more variance in a nonclinically 
ascertained sample.  
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The study also addressed a number of the methodologica  limitations of previous 
studies employing the NES. First of all, the internal consistency of each NES subdomain 
was examined to assess the extent to which each composite tapped meaningful variance 
pertaining to that neurological soft sign domain. Secondly, a detailed manual was 
developed and interrater reliability was computed to maximize the reliable and valid 
assessment of neurological soft signs. Third, the relation between neurological soft sign 
performance on bilateral tasks (across hands) was inspected to determine the most 
appropriate analytic strategy for the data. Finally, regression, rather than zero-order 
correlation, was employed to assess the unique relation of neurological soft signs with 
positive and negative schizotypy, and their interaction term.  
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CHAPTER II 
METHOD 
Participants 
The initial sample included 201 college undergraduates enrolled in introductory 
psychology courses at the University of North Carolina at Greensboro. Participants were 
excluded from the study if they: 1) had a self-reported head injury that resulted in loss of 
consciousness or medical history with clear evidence of neurological illness or injury; 2) 
ever used medications with neurological side effects including anti-convulsants or anti-
psychotics; or 3) had a history of substance abuse that suggested marked functional 
impairment. Based on these criteria, 3 participants were dropped due to head injury, 
medical illness, and/or medication use indicative of neurological insult, and 2 subjects 
were dropped due to a history of substance abuse. In addition, 18 subjects were dropped 
due to unusable schizotypy questionnaire data and one subject was dropped due to 
noncompliance with the procedures. This resulted in a f al sample of 177 participants. 
The sample size provided adequate power (>.80) to obtain a medium effect size based 
upon Cohen’s (1992) recommendations ( = 76, α = .05). A medium effect size was 
hypothesized based on the results from Barkus et al. (2006). The mean age of the sample 
was 19.6 (age range = 15.1 - 32.8). The sample was 74.6% female and 25.4% male, and 
62.1% Caucasian, 24.9% African-American, 4.5% Asian, 2.3% Hispanic, .6% Native-
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American, and 4.0% “other,” with 1.7% of the sample not reporting their ethnicity. The 
demographic characteristics were consistent with the university demographics. 
Materials 
Schizotypy Questionnaires. The schizotypy questionnaires included the Perceptual 
Aberration, Magical Ideation, Physical Anhedonia (Chapman, Chapman, & Raulin, 1976) 
and Revised Social Anhedonia Scales, and a 13-item infrequency scale (Chapman & 
Chapman, 1983). The Perceptual Aberration Scale contains 35 items that tap psychotic-
like perceptual experiences and bodily distortions. The Magical Ideation Scale consists of 
30 items that assess belief in improbable or invalid causality. The Revised Social 
Anhedonia Scale includes 40 items that tap asociality nd indifference towards 
interpersonal relationships. The Physical Anhedonia Sc le is comprised of 61 items that 
assess deficits in sensory and aesthetic pleasure. The Perceptual Aberration and Magical 
Ideation Scales assess positive schizotypy, and the Physical Anhedonia Scale taps 
negative schizotypy. The Revised Social Anhedonia Scale appears to assess both positive 
and negative schizotypy. Exploratory and confirmatory factor analyses of the four scales 
reliably produce two factors, positive and negative schizotypy, that account for 80% of 
the variance (Brown, Silvia, Myin-Germeys, Lewandowski, & Kwapil, 2008; Kwapil et 
al., 2008; Lewandowski, Barrantes-Vidal, Nelson-Gray, Clancy, & Kwapil, 2006). 
Participants were assigned positive and negative schizotypy dimensional scores, based 
upon factor loadings derived from a sample of 6,137 college students (Kwapil et al., 
2008). The schizotypy questionnaires are widely used and have good internal consistency 
(.82-.92). The 13-item infrequency scale was designed to screen out participants who 
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respond in a random or “fake-bad” manner. Following the recommendations of Chapman 
& Chapman (1983), participants who endorsed more than wo of these items were 
omitted from further study.  
 Neurological evaluation. The neurological evaluation was conducted using the 
NES. The NES is a structured instrument used to assess the presence of neurological soft 
signs in schizophrenia. The original NES consists of 26 tasks, with 14 measures assessed 
and scored separately for the right and left side of the body. The battery includes tasks 
that test sensory integration, motor coordination, and motor sequencing. The NES also 
assesses fine motor movement, short-term memory, and eye movement abnormalities, 
and uses a performance-based version of the Annett Qu stionnaire (Annett, 1967) to 
assess cerebral dominance. The NES tasks are scored ordinally on a 3-point scale: 0=no 
abnormality; 1=mild, but definite impairment; and 2=marked impairment. The snout and 
suck reflexes are scored as either 0 or 2. Continuous data including error count and 
completion time were also recorded when possible, consistent with revised scoring 
recommendations by Sanders et al. (1998; 2006). In addition, the original NES battery 
was supplemented with the go-no-go task (Merriam et al., 1990; Sanders et al., 2006) and 
the palmomental reflex (Sanders et al., 1994; Keshavan et al., 2003).  
The original administration and scoring instructions for the NES were rather 
limited. Therefore, a detailed administration and scoring manual was developed to 
maximize the reliability and validity of the study. One of the authors of the NES was 
consulted to clarify several of the procedures (R.W. Buchanan, personal communication, 
March 15, 2007).  
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 All neurological evaluations were performed by a trained graduate student or 
undergraduate research assistant. A total of 50% (89/177) of the participants were scored 
independently by the administrator and a separate rater who also attended the session in 
order to assess interrater reliability.  
Screening Questionnaire. The screening questionnaire consisted of questions 
regarding corrected vision and hearing, medical history, current medication use, drug and 
alcohol use, and history of head injury.    
Procedures 
Most participants attended a two-hour departmental mass screening session at 
which they completed a brief demographic questionnaire and the schizotypy 
questionnaires ranging from two to twelve weeks prior to the neurological assessment. 
The schizotypy scales measure trait-like characteristics and have good stability across 
this time frame (Chapman, Chapman, & Kwapil, 1995). Note that participants who did 
not complete the schizotypy questionnaires at the departmental mass screening or had 
invalid questionnaires from mass screening (due to inc mplete forms or elevated 
infrequency score) completed the schizotypy questionnaires at the time of neurological 
assessment. Participants then volunteered or were invit d to take part in the study. In 
order to ensure adequate inclusion of participants reporting high levels of schizotypy, 
participants who received standard scores > 1.5 on either the positive or negative 
schizotypy dimensions from the mass screening assessments were recruited 
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(oversampled). A total of 24% of the final sample was recruited in this manner, and a 
total of 40% of the recruitment list agreed to take part in the study3. 
The NES and screening questionnaire were individually administered to each 
participant during a one-hour testing session. Participants who had corrected vision or 
hearing needed to have their correction with them to take part in the study. Consent was 
obtained from each participant prior to study enrollment. Participants younger than 18 
years old provided consent from their parents/guardians to participate in the study, as 
well as personally providing assent.  
                                                
3 The recruited group included participants who received standard scores > 1.5 on either schizotypy 
dimension and participants with scores below the cut-offs. Note that in general, the assessors were not 
aware of whether the participants volunteered or were r cruited. Furthermore, none of the recruiters, 
assessors, or raters were aware of any of the partici nts’ scores on the schizotypy measures. 
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CHAPTER III 
RESULTS 
Statistical analyses were conducted using MPlus verion 5.1 (MPlus 5.1, 2008) 
and SPSS version 15 (SPSS, 2006). A series of preliminary analyses were conducted to 
examine the nature of the schizotypy and NES data. 
Schizotypy Data 
Participants were assigned positive and negative schizotypy dimensional scores 
based on a sample of 6,147 college students (Kwapil et al., 2008). The mean, range, and 
distribution of scores were examined for the positive and negative schizotypy dimensions 
(positive schizotypy: mean = -.01, standard deviation = 1.23, minimum = -1.54, and 
maximum = 4.85; negative schizotypy: mean = .29, standard deviation = 1.20, minimum 
= -1.79, and maximum = 3.30). Both positive and negative schizotypy had unimodal 
distributions. The schizotypy dimensions correlated, r = .25, p < .001. 
Relation between Positive and Negative Schizotypy and Handedness 
 Following the recommendations made by Annett (1967), a total of 89% (n=158) 
of participants were classified as right-handed, 7% (n=12) of participants were classified 
as left-handed, and 4% (n=7) of participants were classified as mixed-handed. Given the 
small number of mixed-handed participants, handedness was reclassified as right and 
nonright, in order to examine the relation of handedness and schizotypy. Binary logistic 
regression was used to examine the relation between positive and negative schizotypy 
 
27 
 
and handedness. Positive and negative schizotypy were entered at the first step, so the 
effect of each dimension could be assessed with the other partialed out. The positive x 
negative schizotypy interaction was entered at the second step to examine its effect over 
and above the main effects. There was no relation between positive schizotypy (odds 
ratio = 0.85, 95% confidence interval = 0.54 -1.33), negative schizotypy (odds ratio = 
1.11, 95% confidence interval = 0.75 - 1.65) or the positive x negative schizotypy 
interaction (odds ratio = 1.27, 95% confidence interval = 0.96 - 1.68) and handedness.  
Relation between Dominant and Nondominant Hand Performance 
Polychoric correlations (Drasgow, 1988) were used to examine the relation 
between dominant and nondominant hand performance4 for bilateral tasks for ordinal and 
error count data. A polychoric correlation is appropriate with ordered or categorical data 
to measure agreement, in this case dominant and nondomi ant hand performance 
agreement, and is interpreted in the same manner as a Pearson correlation coefficient. 
Examining the relation between dominant and nondominant hand performance allowed 
us to determine whether it would be appropriate to combine scores from bilateral tasks 
into a single score (e.g., the higher or average score across dominant and nondominant 
hands). However, as seen in Table 2, there was little support for combining ordinal or 
error count data for bilateral tasks. Therefore, ordinal and error count data were analyzed 
separately for dominant and nondominant hands for all subsequent analyses.  
Pearson correlations were used to assess the relation between dominant and 
nondominant hand performance for latency data, given that the latency distributions were 
                                                
4Since there was a subset of mixed-handed participants in the sample, dominant handedness was assigned 
to each participant’s writing hand (and nondominant handedness was assigned to the opposite hand).  
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continuous and normally distributed. Latency data for dominant and nondominant hands 
were highly correlated (see Table 2). Therefore, lat ncy tasks with r > .80 were combined 
into a single variable by taking the average of the dominant and nondominant hands. This 
included the latency data for Rapid Alternating Movements, Finger-Thumb Opposition, 
Fist-Ring, and Fist-Edge-Palm, but not Gaze Impersistence.  
Descriptive Statistics and Interrater Reliability of Neurological Soft Signs 
Table 3 presents the mean, standard deviation, minimum, maximum, skew, 
interrater reliability, and analysis plan for each NES subtest. Traditionally, interrater 
reliability is estimated by Cohen’s kappa coefficient (Cohen, 1960). This statistic is 
appropriate when the same 2 judges rate a variable of interest. Since pairs of raters 
(selected from 6 total judges) rated 50% of the NES sessions (89 out of the 177 sessions), 
Cohen’s kappa statistic was deemed inappropriate. Th refore, a one-way random effects 
model was used to analyze interrater reliability, based on the recommendations of Shrout 
and Fleiss (1979). A one-way random effects model5 is used when each participant is 
rated by a pair of raters from a larger population of judges. In addition, this model 
assumes that it is not possible to separate the effects due to judges, to the interaction 
between judge and target, and to random error. Interrater reliability was excellent with 
mean = .90 and standard deviation = .11 for ordinal data, mean = .93 and standard 
deviation = .08 for error count data, and mean = .99 and standard deviation = .01 for 
                                                
5 A one-way random effects model assumes the following linear model: xij = u + bj +wij, where xij denotes 
the ith rating for the jth target; “u is the overall population mean of theratings; bj is the difference from u of 
the jth target’s so-called true score (i.e., the mean across many repeated ratings on the jt  target); and wij is 
a residual component equal to the sum of the inseparable effects of the judge, the judge x target interaction, 
and the error term” (Shrout & Fleiss, 1979, p.421). 
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latency data (see Table 4 for the interrater reliability values for each subtest). Overall, 
87% of the tasks had interrater reliability above .80.  
Given the concerns noted previously regarding the applicability of the NES for 
use with a nonclinical sample, subtests were dropped that exhibited poor interrater 
reliability (< .70) or minimal response variance (σ  ≤ .32).  The following tasks were 
dropped from the subsequent analyses: Romberg, Stereognosis (ordinal and error count 
data for dominant hand only), Rapid Alternating Movements (ordinal and error count 
data for dominant hand only), Finger-Thumb Oppositin (ordinal data only), Glabellar 
reflex (ordinal data only), Face-Hand Test, Snout Reflex, Suck Reflex, and Palmomental 
Reflex.  
 Note that there were no differences in neurological soft sign rates across sex or 
ethnicity. In addition, neurological soft signs were unrelated to age (although the age 
range was rather restricted in the present study).  
NES Subtest Analyses  
In order to examine the relations of positive and negative schizotypy with 
individual NES tasks, a series of regression analyses were conducted with the ordinal, 
error count, and latency NES subtest scores as the dep ndent variables. In every analysis, 
positive and negative schizotypy were entered at the first step, so the effects of each 
could be assessed with the other partialed out. The positive x negative schizotypy 
interaction was entered at the second step to examine its effect over and above the main 
effects.  
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Note that the skew statistic and qualitative inspection of each distribution for 
ordinal and error count data revealed that the distributions for every NES variable were 
highly skewed in the positive direction, which was expected given the nonclinical sample 
and the low base-rate of neurological soft signs. Therefore, traditional ordinary least 
squares linear regression was deemed inappropriate due to the severe violation of 
normality. Categorical regressions were used to analyze ordinal data, negative binomial 
regressions were used to analyze error count data, and linear regressions were used to 
analyze latency data. Categorical regression is a nonlinear function that does not assume 
an interval scale across categories, but retains the rank order of the variables (Cohen, 
Cohen, West &, Aiken, 2003). Negative binomial regression is a generalized linear model 
that accounts for a highly positively skewed distribut on and is used with count data 
(Agresti, 2007). The negative binomial distribution s unimodal, positively skewed over 
nonnegative integer values, and unlike a Poisson distribution, does not assume 
equivalence of the mean and variance. Negative binomial regression is similar to Poisson 
regression; however, it includes the D parameter in the model which allows the variance 
to be greater than the mean.6 Analysis of the D parameter indicated that the error count 
data had negative binomial, rather than Poisson, distributions.  
Table 4 presents the regression analyses for each NES subtest. In general, 
negative, but not positive, schizotypy was related to neurological soft signs. In particular, 
negative schizotypy was associated with increased neurological soft signs in tasks that 
                                                
6 Note that a Poisson distribution assumes that the mean and variance are equivalent. However, subject 
heterogeneity often results in a variance that is larger than the mean, which is called overdispersion. 
Overdispersion is measured by the dispersion parameter (D), which summarizes the extent of 
overdispersion relative to a Poisson distribution (Agresti, 2007).  
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assessed fine7 and gross motor coordination, motor sequencing, eye movement 
abnormalities, and memory recall. Positive schizotypy was associated with elevated 
neurological soft sign for tasks related to sensory integration dysfunction. The positive x 
negative schizotypy interaction term was generally unrelated to neurological soft signs 
tasks.8 Note that there was no evidence of a speed-accuracy tradeoff on any of the timed 
tasks given that the correlation between latency and performance ranged from r = -.02 to 
.52 for ordinal scores and r = -.03 to .48 for error count scores (negative correlations 
indicate a speed accuracy trade-off).  
NES Composite Analyses  
Prior to examining the relation of schizotypy with the NES composite scores, the 
internal consistency of the composites was examined. Coefficient alpha is problematic 
with highly skewed count and ordinal data and as a result it is difficult to disentangle 
whether a low alpha value is due to the nature of the distribution or the extent to which 
the items hang together. As an alternative procedure, a series of exploratory factor 
analyses (EFA; P. J. Silvia, personal communication, August 1, 2008) were conducted to 
examine the internal consistency of both the original, ordinal NES composites and the 
ordinal NES composites excluding dropped tasks (see Table 5). In the present case, EFA 
is comparable to confirmatory factory analysis for each composite, as each task loads 
                                                
7The schizophrenia literature is inconsistent regarding its classification of involuntary motor abnormalities. 
Therefore, tasks that were in the “others” domain that seemed to tap subtle, diminished coordination or 
control of movement were described as deficits in fine motor coordination.  
8Familywise alpha adjustment was not applied to the results in the present study as it has been criticized to 
the extent that it is overly conservative and reducs statistical power (e.g., O’Keefe, 2003). However, when 
either the original Bonferroni correction or a modified Bonferroni procedure (e.g., Simes, 1986) was 
applied to the data, the majority of the tasks for p sitive schizotypy lost significance whereas the results for 
negative schizotypy were substantively unchanged. 
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onto only one composite measure. Consistent with the NES subtest analyses, ordinal 
composites were specified as categorical distributions. EFA results for original NES 
composites revealed acceptable internal consistency for motor sequencing and poor 
internal consistency for motor coordination and sensory integration. Note that it was not 
possible to compute EFA for the original “other” or NES total composites as one task 
(Snout Reflex) had no variance. EFA results for the NES composites excluding the 
dropped tasks revealed acceptable internal consistecy for motor sequencing (this 
subdomain remained unchanged), improved but still relatively low internal consistency 
for sensory integration, and poor internal consistency for motor coordination, “other”, 
and NES total. Note that it was not possible to run EFA for error count composites.  
Table 6 presents the results for the negative binomial regression analyses for the 
NES composites excluding dropped tasks. As hypothesized, negative, but not positive, 
schizotypy was related to motor coordination, motor sequencing, “other,” and “total” 
NES domains. In addition, the positive x negative schizotypy interaction was 
significantly related to motor coordination and NES “total”, suggesting that participants 
with high scores on negative schizotypy but low scores on positive schizotypy performed 
worse in these domains, over and above the schizotypy main  effects (see Figures 1 and 
2). Contrary to our hypothesis, positive, but not negative, schizotypy was related to the 
sensory integration dysfunction NES domain. The pattern of results was the same with 
the ordinal data for the original NES composites (including all tasks), as well as the error 
count data for the sensory integration and motor sequencing NES composites (with and 
without dropped tasks). Note that it was not possible to compute error count composites 
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for motor coordination, “others”, or NES “total” asthere were some tasks that were not 
rated continuously within each domain.  
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CHAPTER IV 
DISCUSSION 
The Schizotypy Framework 
 Current neurodevelopmental models posit that the vulnerability for schizophrenia 
is expressed across a dynamic continuum of clinical and subclinical impairment referred 
to as schizotypy. This formulation suggests that schizophrenia-spectrum disorders 
represent the most deviant expressions of illness along the schizotypy continuum. In 
addition, schizotypy is conceptualized as multidimensional in nature, with positive and 
negative schizotypy being the most consistently replicated factors. There are many 
benefits to studying the multidimensional construct of schizotypy. First of all, it will 
allow us to investigate relevant etiological factors relatively untainted by the 
consequences of the illness itself. Second, the identification of nondisordered schizotypes 
will allow us to examine factors that either increas  the likelihood of or protect against 
the transition into schizophrenia-spectrum disorders. Finally, considerable effort has been 
made towards the identification of prophylactic trea ment interventions – given that the 
leading treatments for schizophrenia are not curative, but rather provide some degree of 
symptomatic relief and relapse prevention for patients. However, the development and 
implementation of preventative treatments is predicated on the reliable identification of 
people at risk for developing schizophrenia and related disorders. The schizotypy 
framework provides a promising structure for developing such interventions. 
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Numerous lines of evidence support the use of psychometric screening inventories as 
promising points of entry for identifying schizotypic individuals. As noted, scores on 
psychometric scales predict clinical symptoms and neurocognitive impairment in both 
disordered and nondisordered schizotypes. Furthermor , psychometric inventories are 
found to predict the development of schizophrenia-spectrum disorders in longitudinal 
studies (with effect sizes that rival or exceed those f family studies). The use of 
psychometric instruments has been criticized for the extent to which it identifies false 
positives. Obviously, this issue depends in large part on the construct being measured. If 
the target is the development of schizophrenia, the method does result in many false 
positives. However, if the target is identifying schizotypy a la Meehl or Claridge, this 
remains an open question – open in large part becaus  we lack a gold standard and must 
rely on construct validation of an open construct. In fact, this criticism seems to confuse 
construct validity (appropriate in the case of schizotypy), with a diagnostic-based 
criterion validity (seemly more suitable in the case of prodromal cases who are teetering 
on the brink of schizophrenia). Construct validity demands more patience to formulate 
and test hypotheses than does criterion validity. For example, in the Chapman et al. 
(1994) follow-up study, between 5% and 50% of the at-risk samples were psychotic at 
age 30. What does this mean about the remaining 50-95% of the sample? Lacking further 
longitudinal assessments, we do not know if they ar f lse positives, if they are 
schizotypes who will decompensate in the future, or if they are schizotypes who are and 
will remain compensated (likely due to protective factors that we fail to recognize at this 
point). 
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 Construct validation of multidimensional schizotypy requires developing methods 
for identifying schizotypy and then testing predictions about the nature, etiology, and 
expression of schizotypy (across the entire range of the construct). Often this involves 
predictions about mild and transient manifestations f full-blown schizophrenic 
pathology in nondisordered schizotypes.  For example, the finding that psychometrically 
assessed positive schizotypy in nondisordered participants is associated with interview 
reports of psychotic-like symptoms both cross-sectionally and longitudinally (e.g., 
Kwapil et al., 2008; Kwapil, Chapman, & Chapman, 1999) supports the multidimensional 
framework of schizotypy. Furthermore, the combination of schizotypic signs from 
multiple domains (e.g., psychometric screening, subclinical symptoms, neurocognitive 
impairment, and family history) should enhance our identification of individuals at 
markedly high risk for transitioning into spectrum disorders.  
Neurological Soft Signs and Schizotypy 
This study aimed to further the validation of the multidimensional construct of 
schizotypy by investigating the relation between neurological soft signs and 
psychometrically identified positive and negative schizotypy. It appears to be the most 
comprehensive assessment of neurological soft signsin a nonclinically ascertained 
sample to date. Specifically, previous studies suffered from limitations such as: 1) failing 
to examine dimensions of schizotypy; 2) employing measurement of neurological soft 
signs that was limited in terms of domains assessed or the measures employed; and/or 3) 
failing to consider psychometric properties of the data and using inappropriate statistical 
analyses.  
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As hypothesized, negative, but not positive, schizotypy was related to increased 
neurological soft signs in tasks that assessed fine and gross motor coordination, motor 
sequencing, eye movement abnormalities, and memory recall. However, positive 
schizotypy was associated with elevated neurological soft signs in tasks related to sensory 
integration dysfunction. In general, the positive x negative schizotypy interaction term 
was unrelated to neurological soft signs tasks. These r sults are generally consistent with 
the schizophrenia literature and support the multidimensional framework of schizotypy. 
Note that the psychometric screening inventories did not inquire about neurological, 
neurocognitive, or neuromotor deficits – so the results are not simply due to overlapping 
content in the predictors and criteria. Furthermore, th  schizotypy dimensional scores 
identified elevated rates of neurological soft sign in participants who were drawn from a 
nonclinically ascertained sample and who were functio ing well enough to enroll in a 
major university (making for an especially conservative test of the hypotheses).  
 The present findings are consistent with the notio that negative schizotypy serves 
as a trait-like expression of subtle neurological impairment, whereas positive schizotypy 
reflects an oscillating neurochemical imbalance. Although the above statement is 
undoubtedly an oversimplification of the complex processes underlying the development 
of positive and negative schizotypy (e.g., it is well known that hypodopaminergic 
functioning is related to negative schizotypy), it does suggest that the etiology underlying 
the dimensions may be separate, but related disease proc sses. Conceptualizing and 
measuring positive and negative schizotypy (and by extension schizophrenia) in this 
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manner may help to clarify mixed findings in literature – which often treats schizophrenia 
spectrum disorders as discrete and homogenous entities.  
The finding that elevated neurological soft sign tasks assessing fine and gross 
motor coordination and motor sequencing were related to negative schizotypy support 
current neurodevelopmental models of schizophrenia. Specifically, Andreasen’s (1999) 
theory of ‘cognitive dysmetria’ suggests that disruptions in the cortico-cerebellar-
thalamic-cortical circuit (CCTCC), which is normally used to coordinate and sequence 
motor and cognitive activity, leads to abnormal output that characterizes the expression 
of schizotypy (and thus, schizophrenia). Moreover, Andreasen suggested that three 
“nodes” in the CCTCC may be particularly important in schizophrenia – the cerebellum, 
the prefrontal cortex, and the thalamus. It is well known that the cerebellum is involved 
in motor movement and increasing evidence corroborates its role in the etiology of 
schizophrenia (in contrast to previous views that te cerebellum played little role in the 
expression of higher human functions). In fact, brain imaging studies have shown that 
volumetric decreases in the cerebellum are related to deficits in tasks associated with 
motor coordination (e.g., Bottmer et al., 2005) andmotor sequencing (e.g., Keshavan et 
al., 2003) in patients with first-episode schizophrenia. Moreover, in her seminal studies 
employing archival videotapes, Walker et al. (1990) showed that abnormal motor 
movements in early childhood discriminated siblings who developed schizophrenia from 
siblings who did not and later predicted enlarged vntricles in adult patients (Walker, 
Lewine, & Neumann, 1996). The finding that motor deficits appear prior to the onset of 
cognitive and affective symptoms of schizotypy and schizophrenia is consistent with the 
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“back to the front” theory of synaptic pruning in adolescence (Rappaport, Addington, & 
Frangou, 2005). Taken together, the findings from the present study and previous 
literature suggest that neural dysmaturation may disturb the CCTCC and result in 
abnormal motor movement that can be observed along the negative schizotypy 
continuum dating back to early childhood. Thus, motor dysfunction may serve as an early 
risk marker for schizophrenia.  
Deficits in memory recall were also associated with negative schizotypy. This is 
consistent with an extant literature suggesting that memory dysfunction is a hallmark 
feature of schizophrenia. Imaging studies (e.g., Crespo, Paradiso, Andreasen, O’Leary, 
1999) have linked memory recall deficits to decreases in cerebral blood flow across the 
CCTCC in patients with schizophrenia, supporting a generalized neurological deficit 
across interconnected “nodes”. In addition, the finding that verbal memory dysfunction 
has been observed at illness onset and in putative schizotypes (e.g., Eastvold, Heaton, & 
Cadenhead, 2007) supports its use as a risk marker for schizophrenia. Speaking more 
broadly, one question is whether biobehavioral markers such as neurological soft signs 
and cognitive deficits such as memory recall tap the same underlying neural substrate. 
Although this relation needs to be investigated more thoroughly, memory recall was 
either unrelated or modestly correlated with neurological soft signs tasks in the present 
study, suggesting that they may be related but distinct phenomena. Therefore, assessing 
these risk measures in conjunction with one another may increase our ability to reliably 
identify people along the negative schizotypy continuum.  
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The present study also found that negative schizotypy identified elevated levels of 
eye movement abnormalities. This is consistent witha considerable literature 
documenting the presence of smooth pursuit eye and s ccadic movement abnormalities in 
patients with schizophrenia (e.g., Levy & Holzman, 1997) and putative schizotypes 
identified by consanguinity (e.g., Holzman, Soloman, Levin, & Waternaux, 1984) or 
psychometric inventories (e.g., Gooding, Miller, & Kwapil, 2000). Eye movement 
abnormalities are thought to reflect an impaired motion processing system in the middle 
temporal lobe, rather than a deficit in vision, per se (Holzman, 2000). This suggests that 
neural dysmaturation may affect the motion processing c rcuit and result in abnormal eye 
movements across the negative schizotypy continuum. Ad ittedly, the tasks embedded 
within the NES are rather crude estimates of eye move ent abnormalities. However, 
consistent with our hypotheses, these deficits were still seen along the negative 
schizotypy continuum which suggests that they may be particularly useful biobehavioral 
risk markers for schizophrenia. 
Contrary to the predictions, positive schizotypy was associated with deficits in a 
few tasks related to sensory integration dysfunctio. The literature generally supports an 
association between this domain and negative symptos; therefore it is unclear why the 
opposite results were found in the present study. One hypothesis is that the sensory 
integration tasks are too easy for use with a high functioning sample and thus the results 
represent a Type I error rather than an underlying relation between positive schizotypy 
and sensory integration. An alternative explanation may relate to sensory gating – the 
central nervous system’s ability to regulate sensitivity to sensory input from the 
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environment (Braff & Geyer, 1990). One study recently showed that deficits in sensory 
gating were associated with elevated positive sympto s in patients with schizophrenia 
(Johannesen, Bodkins, O’Donnell, Shekhar, & Hetrick, 2008). It may be that in order to 
integrate information from different sensory domains, one must first regulate or “block 
out” irrelevant sensory stimuli. Therefore, sensory integration and sensory gating may be 
overlapping constructs that influence one another and affect the expression of positive 
symptoms. Ultimately, however, this needs to be examined empirically. 
Finally, the positive x negative schizotypy interaction term was generally 
unrelated to neurological soft signs tasks after partialing out variance associated with the 
main effect. The general lack of findings between the positive schizotypy main effect and 
the schizotypy interaction term further supports negative schizotypy as an expression of 
neural dysmaturation. A relation between neurological soft signs and the main and 
interaction effects may be seen at clinical levels of positive symptom schizophrenia (e.g., 
experiencing hallucinations and delusions). However, this may be due to the disruption of 
positive symptoms on a participant’s ability to understand instructions and perform tasks 
accurately – rather than neurological impairment, per se.   
Taken together, the results from the present study s ggest that neurological soft 
signs may serve as an index of neural dysmaturation nd thus may be a useful marker of 
risk for schizophrenia. In fact, neurological soft signs, particularly those related to motor 
coordination, recently have been proposed as an endophenotype for schizophrenia (Chan 
& Gottesman, 2008). Specifically, Chen and Gottesman suggested that neurological soft 
signs meet the criteria for qualifying as an endophenotype as they: 1) are associated with 
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schizophrenia in the population; 2) are heritable; 3) are primarily state-independent; 4) 
are found in unaffected family members at higher rates than the general population; 5) 
co-segregate within families; and 6) can be measured reliably. However, given that neural 
dysmaturation is not unique to schizotypy or schizophrenia, it is necessary to measure 
neurological soft signs in conjunction with other biobehavioral markers. We plan to 
assess the relation between neurological soft signs and other markers such as obstetric 
complication, dermatoglyphic and minor physical anomalies, neurocognitive functioning, 
as well as interview measures, in order to increase the reliable identification of people 
along the schizotypy continuum.  
The Utility of the Neurological Evaluation Scale 
Another goal of this study was to address the methodological limitations of 
previous research and to determine whether the NES is a useful measure for nonclinically 
ascertained samples. Specifically, this study extended the NES literature by: 1) 
examining the distribution and interrater reliability of individual tasks and using 
appropriate statistical analyses; 2) assessing the in ernal consistency of the composites; 3) 
comparing an ordinal and continuous scoring modality; and 4) measuring the agreement 
between dominant and nondominant hand performance o bilateral tasks. 
Recommendations are offered for future research employing the NES.  
NES tasks. Individual NES tasks were highly positively skewed, with a few tasks 
displaying little response variance and/or unacceptable interrater reliability. The tasks 
that were excluded from the present study are relativ y consistent with the 
recommendations made by Sanders et al. (1998), who proposed an abbreviated version of 
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the NES. Therefore, it is recommended that these tasks should either be dropped from 
future studies with nonclinical samples or modified to increase the difficulty level or 
measurement sensitivity. For example, one task that was dropped from this study was the 
Romberg – a task on which patients with schizophrenia typically perform deviantly. 
Rather than visually examining the degree of “sway” ( s is done with the NES), a 
modified version of the Romberg task could use force platforms that measure shifts in 
mass while participants stand upright (e.g., Marvel, Schwartz, & Rosse, 2004). This 
measurement technique may help to reliably detect milder expressions of this 
neurological soft sign in nondisordered schizotypes.   
One concern prior to the start of the study was whether participants drawn from a 
nonclinical sample would exhibit variability on the tasks or whether the tasks would be so 
simple that most or all participants would perform without errors. Overall, the results 
indicate that the latter was not the case and that the variability in task performance was 
systematically related to schizotypy. However, as noted, several tasks were dropped 
because of little or no variance in participants’ performance. The question remains 
whether this indicates that: 1) the neurological processes tapped by these tasks really are 
not exhibited by nondisordered schizotypes (i.e., that hey represent episode markers 
rather than broad indicators of schizotypy), or 2) the tasks were too simple to capture 
subtle deviancy presumed to characterize schizotypy. Ultimately, this needs to be 
examined empirically.  
In addition to modifying or dropping certain subtests, it is suggested that future 
studies report specific distribution values (e.g., skew and kurtosis statistics) for each NES 
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task. Given the dearth of information about this issue in the literature, the present study 
measured neurological soft signs across the schizotypy continuum to examine the 
underlying nature of each task. Nearly all subtests were highly positively skewed; 
therefore, parametric analyses, which are ordinarily used in the NES literature, were 
deemed inappropriate for the nature of the data. Following this, it is recommended that 
future researchers consider whether parametric or nonparametric statistical techniques 
should be used before beginning their analyses, particularly for nonclinical samples. Not 
only will reporting distributions help researchers develop a statistical plan, but it will aid 
in research design. Since neurological soft signs were highly positively skewed in the 
present study, a more powerful approach may have been to sample participants from the 
high and low end of positive and negative schizotypy, rather than across the entire 
continuum. However, this solution may be unsatisfactory because it relies on setting 
arbitrary cut-points and assumes that there is not meaningful variance related to 
schizotypy below a certain level. Alternatively, nonlinear regressions could examine 
whether there is a curvilinear relation that suggests a point of inflection. Taken together, 
researchers should explicitly examine and report distribution and interrater reliability 
values to strengthen their own study and inform future research projects.  
NES composites. Given that internal consistency values of NES composites are 
rarely reported in the literature, the present study examined the internal consistency of all 
NES subdomains. Only the motor sequencing composite (both original and excluding 
dropped tasks) had acceptable internal consistency. I  order to strengthen the reliability 
of this domain even further, it is recommended thatap reproduction should be dropped 
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from the composite given its low correlation with the other measures. Sensory 
integration, motor coordination, “others” and NES “total” had relatively poor internal 
consistency. Thus, the present status of these composites does not appear to be useful for 
nonclinical samples. This suggests that the composites need to be recreated or modified 
to increase the reliability of these neurological soft ign domain. In addition, future 
research should consider developing a “motor sequencing latency” composite, since the 
measures within this domain correlated highly with one another. Note that composite 
regression analyses were not run with latency data given that not all tasks within the 
composite could be scored in this manner. Regardless of the option that is chosen, 
internal consistency values need to be reported for composite indices. Given the 
relatively poor internal consistency of the NES subdomains (with the exception of motor 
sequencing), composite results (Table 6) should be interpreted cautiously. However, 
since the consensus in the schizophrenia literature strongly holds that negative, but not 
positive symptoms are related to neurological soft igns, it may be that the effect of 
negative schizotypy on the expression of neurological soft signs is so large that it is seen 
even with unreliable subdomains. Research employing more reliable composites is 
needed to clarify this issue in a sample of psychometrically identified positive and 
negative schizotypy.  
Scoring system modalities. This study also compared the original, ordinal scoring 
system (Buchanan & Heinrichs, 1989) with a recently proposed continuous scoring 
system (Sanders, 1998; Sanders et al., 2006) that recorded errors and latency. Note that 
both methods produced good to excellent interrater reliability. Although the results from 
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the regression analyses were comparable across both ystems, the continuous system 
captured more variance and had higher interrater reliability values compared to the 
ordinal system. Therefore, the continuous scoring method appears to be superior to the 
ordinal system and is recommended for use with nonclinical samples who are expected to 
display a milder expression of neurological soft sign .  
Bilateral tasks. Contrary to the way bilateral tasks are traditionally treated in the 
NES literature, this study demonstrated that there was little support to combine or 
collapse bilateral task scores for ordinal or error count tasks (although there was support 
for latency tasks). Thus, future research should examine this association empirically 
before deciding how to treat bilateral tasks. Note handedness was unrelated to schizotypy, 
although the findings are mixed in the literature.  
It is also recommended that handedness is coded as dominant/nondominant rather 
than right/left. This will allow researchers to understand the relation between 
neurological soft signs and cerebral lateralization – two phenomena proposed to underlie 
the etiology of schizophrenia. Although examining this association was beyond the scope 
of this project, we plan to assess the relation of per ormance disparity between hands on 
bilateral tasks with positive and negative schizotypy. Crow (e.g., Crow, 1989) suggested 
that hemispheric asymmetry is reduced in patients with schizophrenia. Therefore, one 
hypothesis may be that less performance disparity across hands is related to negative 
schizotypy.  
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 In summary, the majority of individual tasks of the NES appear to be useful 
measures of neurological soft signs. However, modificat ons are needed in order to 
strengthen the overall utility of the NES battery within a nonclinical sample.  
Implications     
Given that neurological soft signs may be conceptualized as a phenotypic 
expression of neural dysmaturation that is intermediat  between genetic expression and 
the clinical disorder, the results from this study support schizotypy as an expression of 
neurodevelopmental vulnerability for schizophrenia. Moreover, the results corroborate 
the notion that neural dysmaturation predates the app rance of schizophrenia and can be 
detected across the schizotypy continuum. In addition, he differential relation between 
neurological soft signs and positive and negative schizotypy supports the 
multidimensional construct of schizotypy. This does not mean, however, that schizotypy 
is limited to only two factors. Although the positive and negative symptom dimensions 
are the most widely reported factors of schizotypy and schizophrenia, the focus on and 
identification of these factors admittedly reflects the nature of the measures administered.  
There is considerable controversy regarding the underlying nature of schizotypy. 
The predominately European notion, as espoused by Claridge (1984), considers 
schizotypy to be a normal dimension of personality (fully dimensional model), while the 
predominately North American conceptualization, as set forth by Meehl (1962), considers 
schizotypy to represent the expression of a pathological process of neurodevelopment 
that is taxonic in nature. Taxometric methods and fi ite mixture modeling have been used 
to support the notion of a schizotypic taxon (Lenzenweger & Korfine, 1992; 
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Lenzenweger, McLachlan, & Rubin, 2007). However, both the North American and 
European conceptualizations are consistent with a multifactorial structure for schizotypy 
in which schizotypic traits are distributed across continua of increasing severity. The 
models differ on whether these dimensions are continuous or discontinuous with the 
general population. It is important to note that the present study focused on further 
validating the multidimensional structure of schizotypy, not resolving the issue of 
whether schizotypy is fully dimensional or taxonic in nature. However, the reliable 
identification of these underlying dimensions should facilitate the resolution of this larger 
issue. 
The current findings also support the use of psychometric screening inventories 
for detecting meaningful variation related to schizotypy and neurological soft signs. 
Future studies should employ the psychometric method o assess the relation between 
schizotypy and multiple domains of risk including biobehavioral, cognitive, and affective 
features to reliably indentify people along the schizotypy continuum. This will provide a 
platform for longitudinal study, which will aid in our understanding of the development 
and expression of schizotypy and will ultimately contribute to the development of 
prophylactic interventions. 
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APPENDIX. TABLES AND FIGURES 
 
 
Table 1. Description of NES subscales and subtests  
Subscale Subtest Subtest Description 
Sensory Integration Audio-visual integration Matches auditory tapping sounds with visually presented dots. 
 Stereognosis*# Identifies an object in hand with eyes closed. 
 Graphesthesia*# Identifies a number written on the tip of forefinger with eyes closed. 
 Extinction Identifies if touched on either right/left cheek, hand, or both. 
  Right/left confusion Points to right or left body parts of self or examiner. 
Motor Coordination Tandem walk Walks in a straight line for 12 feet, heel to toe. 
 Rapid alternating movements*# Alternates slapping leg with palm and back of hand. 
 Finger-thumb opposition*# Touches the tip of fingers (from forefinger to pinky) with the tip of thumb. 
  Finger-nose test*# Touches tip of nose with tip of index finger with eyes closed. 
Motor Sequencing Fist-ring*# Alternates hand positin between fist and ring. 
 Fist-edge-palm*# Alternates hand position between fist, edge of hand, and palm. 
 Ozeretski Simultaneously alternates both hands between fist and palm-down positions.  
  Tap Production Produces a series of taps. 
Other Romberg test Stands with arms held parallel to the floor with eyes closed for one minute. 
 Adventitious overflow# Examiner assesses fluttering movement in fingers, hands, arms during Romberg. 
 Tremor# Examiner assesses hand tremor during Romberg. 
 Memory Recalls four words at 5 and 10 minute intervals. 
 Tap Reproduction Reproduces a series of auditory taps. 
 Mirror Movements*# Examiner assesses parallel moveents of fingers during finger-thumb opposition. 
 Synkinesis# Follows a pen cap with eyes only betwen right and left horizontal visual field. 
 Convergence# Follows a pen cap with eyes only as cap is moved toward nose. 
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 Gaze impersistence*# Fixes gaze on pen cap at a 45 degree angle in right and left horizontal visual fields. 
 Glabellar reflex Examiner assesses blinking when glabllelar region is tapped. 
 Snout and Suck reflexes Tongue depressor is placed against philtrum to assess puckering and pursing of lips. 
 Grasp reflex*# Examiner assesses flexion of fingers when palm is stroked. 
*Indicates right and left side assessed separately, #Indicates right and left side scored separately  
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Table 2. Relation between dominant and nondominant h d for bilateral tasks. 
    
NES Task Ordinal1 Error1 Latency2 
    
Stereognosis     -.01    .03  
    
Graphesthesia .53*** .49***  
    
Rapid Alternating Movements     -.01    .11 .93*** 
    
Finger-Thumb Opposition      .50** .39***      .90*** 
    
Finger-Nose Test .37***   
    
Fist-Ring .79*** .47*** .91*** 
    
Fist-Edge-Palm .45*** .45*** .92*** 
    
Adventitious Overflow .97***   
    
Tremor .96***   
    
Mirror Movements .58***   
    
Synkinesis .55***   
    
Convergence .95***   
    
Gaze Impersistence .51***      .23** 
    
Grasp Reflex .80***   
    
Palmomental Reflex  .39***  
    
    
    
1Polychoric correlation 
2Pearson correlation  
**p<.01   ***p<.001    
 
 
 
Table 3. Descriptive Statistics.        
        
Task Mean SD Min Max Skew IRR Analysis Plan 
        
Audivisual Integration        
        Error count .42 .74 0 3 1.85 .97 Negative Binomial Regression 
        Ordinal .39 .65 0 2 1.43 .96 Categorical Regression 
Stereognosis        
        Dominant - Error count .04 .20 0 1 4.77 .85 Drop 
        Nondominant - Error count .27 .47 0 2 1.40 .92 Negative Binomial Regression 
        Dominant - Ordinal .05 .21 0 1 4.42 .85 Drop 
        Nondominant - Ordinal .26 .46 0 2 1.44 .92 Categorical Regression 
Graphesthesia        
        Dominant - Error count .83   1.01 0 4 1.27 1.00 Negative Binomial Regression 
        Nondominant - Error count .63 .84 0 4 1.37 1.00 Negative Binomial Regression 
        Dominant - Ordinal .74 .79 0 2   .50 1.00 Categorical Regression 
        Nondominant - Ordinal .57 .72 0 2   .86 1.00 Categorical Regression 
Face-Hand Test        
        Error count .04 .22 0 2 6.23   .66 Drop 
        Ordinal .04 .22 0 2 6.23  .66 Drop 
Right-Left Confusion        
        Error count .86 .97 0 4   .82 .98 Negative Binomial Regression 
        Ordinal .79 .84 0 2   .41 .99 Categorical Regression 
Tandem Walk        
        Error count .16 .45 0 2 2.94 .96 Negative Binomial Regression 
        Ordinal .19 .52 0 2 2.75 .98 Categorical Regression 
Rapid Alternating Movements        
        Dominant - Error count .06 .29 0 2 5.03  1.00 Drop 
        Nondominant - Error count .15 .45 0 3 3.41  1.00 Negative Binomial Regression 
        Dominant - Latency 14.12   3.07     7.58    35.00 2.49  .99 Linear Regression 
        Nondominant - Latency 14.02   3.10     8.49    36.00 2.68  .97 Linear Regression 
        Average Latency 14.06   3.03     8.04    35.50 2.71  .99 Linear Regression 
        Dominant - Ordinal .05 .22 0 1 4.12  .79 Drop 
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        Nondominant - Ordinal .12 .34 0 2 2.80  .95 Categorical Regression 
Finger-Thumb Opposition        
        Dominant - Error count .31 .68 0 4 2.99  .79 Negative Binomial Regression 
        Nondominant - Error count .32 .67 0 3 2.29  .76 Negative Binomial Regression 
        Dominant - Latency 12.40   2.85      6.09    23.72 1.04  .98 Linear Regression 
        Nondominant - Latency 12.37   2.77     7.00    23.06 1.09  .98 Linear Regression 
        Average Latency 12.39   2.74     7.06    23.39 1.07  .99 Linear Regression 
        Dominant - Ordinal .07  .31 0 2 4.98 * Drop 
        Nondominant - Ordinal .08 .30 0 2 3.63  .86 Drop 
Finger-Nose Test        
        Dominant - Ordinal .60 .68 0 2   .69  .87 Categorical Regression 
        Nondominant - Ordinal .66 .70 0 2   .58  .84 Categorical Regression 
Fist-Ring        
        Dominant - Error count  1.09   1.47 0 9 2.21  .94 Negative Binomial Regression 
        Nondominant - Error count .66   1.21 0 7 2.53  .95 Negative Binomial Regression 
        Dominant - Latency 30.26   7.42    14.42    67.00 1.42  .96 Linear Regression 
        Nondominant - Latency 29.41   7.14    14.67    62.87 1.27  .99 Linear Regression 
        Average Latency 29.84   7.12    14.55    59.33 1.27  .99 Linear Regression 
        Dominant - Ordinal .20 .50 0 2 2.48  .83 Categorical Regression 
        Nondominant - Ordinal .15 .40 0 2 2.78  .89 Categorical Regression 
Fist-Edge-Palm        
        Dominant - Error count   1.85   1.79 0       12 1.77  .97 Negative Binomial Regression 
        Nondominant - Error count   1.07   1.24 0          5 1.22  .92 Negative Binomial Regression 
        Dominant - Latency 42.02 8.54    23.84   70.53   .57  .94 Linear Regression 
        Nondominant - Latency 41.02 9.14    23.39   87.06 1.33  .99 Linear Regression 
        Average Latency 41.52 8.67    23.62   78.69   .94  .98 Linear Regression 
        Dominant - Ordinal   .47  .64 0        2 1.02  .88 Categorical Regression 
        Nondominant - Ordinal   .21  .45 0        2 2.00  .71 Categorical Regression 
Ozeretski        
        Error count   3.91   5.25 0        30 2.57  .98 Negative Binomial Regression 
        Latency 18.48   5.39       8.69    42.00 1.19  .96 Linear Regression 
        Ordinal   .79  .85 0 2   .42  .96 Categorical Regression 
Tap Production        
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        Error count .40  .82 0 5 2.82  .88 Negative Binomial Regression 
        Ordinal .34  .61 0 2 1.59  .96 Categorical Regression 
Romberg        
        Ordinal .06  .26 0 2 4.87 * Drop 
Adventitious overflow        
        Dominant - Ordinal .49  .65 0 2 1.00  .89 Categorical Regression 
        Nondominant - Ordinal .46  .65 0 2 1.11  .92 Categorical Regression 
Tremor        
        Dominant - Ordinal .14  .41 0 2 3.02  .74 Categorical Regression 
        Nondominant - Ordinal .12 .38 0 2 3.32  .61 Categorical Regression 
Memory - 5 minute delay        
        Error count .33 .61 0 3 1.81  1.00 Negative Binomial Regression 
        Ordinal .33 .59 0 2 1.63  1.00 Categorical Regression 
Memory - 10 minute delay        
        Error count .40 .63 0 3 1.49  1.00 Negative Binomial Regression 
        Ordinal .39 .61 0 2 1.33  1.00 Categorical Regression 
Tap Reproduction        
        Error count 1.05 1.05 0 5   .99  .90 Negative Binomial Regression 
        Ordinal .95 .85 0 2   .09  .94 Categorical Regression 
Mirror Movements        
        Dominant – Ordinal .82 .56 0 2   .05  .91 Categorical Regression 
        Nondominant - Ordinal .67 .55 0 2   .03  .74 Categorical Regression 
Synkinesis        
        Dominant – Ordinal .29 .55 0 2 1.76  .95 Categorical Regression 
        Nondominant - Ordinal .28 .50 0 2 1.56  .93 Categorical Regression 
Convergence        
        Dominant – Ordinal .40 .57 0 2 1.09  .88 Categorical Regression 
        Nondominant - Ordinal .46 .64 0 2 1.06  .79 Categorical Regression 
Gase Impersistence        
        Dominant - Latency   1.28    4.63 0    24.1 3.72  1.00 Censored Regression 
        Nondominant - Latency  1.31    4.64 0       26.23 3.91  1.00 Censored Regression 
        Dominant - Ordinal .11 .36 0 2 3.58   .96 Categorical Regression 
        Nondominant - Ordinal .13 .41 0  2 3.34  1.00 Categorical Regression 
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Glabellar Reflex        
        Error count   1.29    1.43 0        10 2.05   .76 Negative Binomial Regression 
        Ordinal .08 .30 0  2 3.63   .65 Drop 
Snout Reflex         
        Ordinal .00 .00 0  0  ** Drop 
Grasp Reflex        
        Dominant - Ordinal .16 .45 0  2 2.85  1.00 Categorical Regression 
        Nondominant - Ordinal .10 .35 0  2 3.73   .89 Categorical Regression 
Suck Reflex         
        Ordinal .02 .22 0  2 9.11  1.00 Drop 
Palmomental Reflex        
        Dominant - Error count .31 .93 0  7 4.67   .38 Drop 
        Nondominant - Error count .32   1.42 0        15 7.71   .59 Drop 
Go-No-Go Task         
        Error count .71   1.16 0  7 2.38   .97 Negative Binomial Regression 
        
        
*Negative average covariance        
**No variance        
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Table 4. NES Subtests  Ordinal   Error   
Average 
Latency1  
 Step 1   Step 2 Step 1   Step 2 Step 1   Step 2 
 Positive Negative  Positive Negative  Positive Negative  
 Schizotypy Schizotypy PXN Schizotypy Schizotypy PXN Schizotypy Schizotypy PXN 
NES Criterion β β β B B B β β Β 
Audiovisual 
Integration         .01       -.07         0        .03        .01        .03     
Stereognosis             
        Nondominant       -.03        .13       -.10       -.01        .17@       -.01     
Graphesthesia             
        Dominant        .02        .02       -.16@        .01        .08       -.15*     
        Nondominant        .17*       -.03       -.09        .12@       -.03       -.05     
Right Left Confusion        .16*        .09        .06        .14**        .07         0     
Tandem Walk       -.21        .27*       -.03       -.26        .38*       -.13     
Rapid Movements               -.12       -.02 .14 
        Nondominant        .11        .06       -.03        .02        .08        .01     
Finger-Nose             
        Dominant        .08        .03       -.06         
        Nondominant        .13        .09       -.15@         
Fist-Ring                .03        .07  .15@ 
        Dominant       -.13        .15       -.01       -.06        .16@         0     
        Nondominant       -.04        .14       -.19       -.04        .10       -.16@     
Fist-Edge-Palm               -.01        .10 
      
.17@ 
        Dominant        .11        .22**       -.01        .04        .16**         0     
        Nondominant        .02        .08       -.05        .03        .04       -.06     
Ozeretski        .03        .16*         0        .02        .16@       -.03       -.02        .06  .06 
Tapping Production        .02         0       -.11       -.05        .04       -.08     
Adventitious Overflow             
        Dominant       -.09        .18*        .12         
        Nondominant         0        .16*        .06         
Tremor             
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        Dominant        .16        .21@         0         
        Nondominant        .10       .36***       -.06         
Memory - 5 min delay       -.05        .24**       -.11       -.04        .26**       -.11     
Memory - 10 min delay       -.14       .26***       -.17       -.13        .26***       -.15@     
Tapping Reproduction        -.04        .03       -.07       -.03        .01       -.05     
Finger-Thumb 
Opposition               -.10        .08   .14 
        Dominant           -.06        .06       -.01     
        Nondominant           -.22        .18       -.01     
Mirror Movements             
        Dominant        .16@        .06       -.07         
        Nondominant        .17*       -.03        .01         
Synkinesis             
        Dominant        .07        .13       -.31*         
        Nondominant      -.17@       .32***        .07         
Convergence             
        Dominant       -.09        .07       -.10         
        Nondominant       -.03        .17*        .05         
Gaze Impersistence             
        Dominant        .01        .01        .03            .26        .73   .28 
        Nondominant       -.01       -.13        .15           -.37     -2.39 2.18 
Glabellar Reflex           -.11@        .08        .02     
Grasp Reflex             
        Dominant       -.03 
       
.29***       -.34*         
        Nondominant        .12        .01       -.14         
Go-No-Go Task              .20*        .14       -.10       
PXN = Interaction @p<.10  *p<.05   **p<.01   ***p<.001      
1Latency data for Gaze Impersistence was examined separately for dominant and nondominant hands. 
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Table 5. Exploratory factor analyses for NES composites.       
        
NES Domain Chi-Square Test  
Chi-Square Test  
of Model Fit for the CFI TLI RMSEA SRMR 
Minimum  
Rotation  
  of Model Fit Baseline Model         Value 
Sensory Integration (all tasks) X2 = 51.41**, df= 14 X2 = 120.42** , df = 21 .62 .44 .123 .126 2.159 
Sensory Integration (no dropped tasks) X2 = 11.59*, df = 5 X2 = 51.90** , df=10 .84 .69 .086 .083 1.171 
Motor Coordination (all tasks) X2 = 89.22**, df = 21 X2 = 89.22** , df=21 0 0 .135 .130 **** 
Motor Coordination (no dropped tasks) X2 = 24.36**, df = 6 X2 = 24.36** , df=6 0 0 .131 .039 23181.92 
Motor Sequencing (all tasks) X2 = 12.33, df = 9 X2 = 286.32** , df=15 .99 .98 .046 .072 2.424 
Other (no dropped tasks) X2 = 1790.56**, df=152 X2 = 15300.95**, df=171 .89 .88 .247 .331 7.787 
NES total (no dropped tasks) X2 = 2860.06**, df=527 X2 = 16588.62**, df=561 .85 .85 .158 .239 8.502 
*p<.05, **p<.001 
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Table 6. NES Composites Excluding Dropped Tasks.   
  
 
Ordinal  
 Step 1   Step 2 
 Positive Negative  
 Schizotypy Schizotypy Interaction 
NES Criterion B   B B 
Sensory Integration Dysfunction          .07*              03          -.04@ 
Motor Coordination          .05             .11*         -.07* 
Motor Sequencing          .01             .16*         -.03 
Others          .01             .11**         -.05@ 
Total          .02             .11***         -.05** 
@p<.10  *p<.05  **p<.01 
***p<.001    
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Figure 1. Simple slopes analysis exhibiting the interaction between the predictions of    
  positive and negative schizotypy and motor coordination (excluding dropped tasks). 
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Figure 2. Simple slopes analysis exhibiting the interaction between the predictions of  
  positive and negative schizotypy and NES total (excluding dropped tasks). 
 
 
 
 
 
 
 
 
 
 
